← All peptides
Hormones & TRT
Clinical

Exemestane

Also known as: Aromasin

A steroidal (irreversible) aromatase inhibitor used off-label as an alternative to anastrozole for controlling estrogen on testosterone therapy. Prescription medication (approved for breast cancer).

Last updated

Mechanism of Action

Exemestane is a steroidal 'suicide' aromatase inhibitor: it binds aromatase irreversibly and permanently inactivates the enzyme, lowering the conversion of testosterone to estradiol. Because the enzyme must be regenerated, it avoids some of the rebound seen with reversible inhibitors. As with any aromatase inhibitor, some estradiol is essential for male health, so over-suppression is harmful and dosing is conservative and lab-guided.

Half-life
~24 hours (enzyme effect lasts longer due to irreversible binding)
Administration Routes
Oral
Research Status
Clinical

Reported Benefits

  • Lowers elevated estradiol on testosterone therapy
  • Irreversible action avoids the estrogen rebound of reversible AIs
  • Generally neutral effect on lipids at low doses

Potential Side Effects

  • Over-suppression of estradiol (joint pain, low libido, mood changes)
  • Reduced bone mineral density with excessive use
  • Fatigue

Common Dosing

When used, protocols report low doses a few times weekly, titrated to estradiol labs. Many men on well-managed TRT need no aromatase inhibitor. Physician-directed only.

The dosing information above is aggregated from research literature and anecdotal community reports for educational purposes only. It is not a recommendation, prescription, or medical advice. Peptides are sold as research chemicals only and are not intended for human use.

Contraindications

  • Women who are or may become pregnant
  • Osteoporosis / low bone density (relative)
  • Do not drive estradiol below the healthy male range
  • Pharmacokinetics and dose finding of a potent aromatase inhibitor, aromasin (exemestane), in young males

    2003

    View
  • A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer

    2004

    View
  • Exemestane for breast-cancer prevention in postmenopausal women

    2011

    View
  • Overview of the pharmacology of the aromatase inactivator exemestane

    2002

    View

Both lower estradiol. Anastrozole is reversible; exemestane is steroidal and binds aromatase irreversibly, which can avoid rebound. Choice is individual and lab-guided — and many men need neither. Prescription-directed.

PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.